{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-22-001432","form_type":"8-K","ticker":"IGC","cik":"0001326205","company_name":"IGC Pharma, Inc.","filed_at":"2022-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.162218+00:00","generated_at":"2026-06-21T01:32:04.344812+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"low","headline":"IGC posts updated life sciences presentation on website; no financial or clinical updates","bullets":["Presentation covers low-dose THC drug formulation and disease treatment initiatives.","Also highlights cannabinoid consumer product lines including Holief and Sunday Seltzer.","No new clinical trial results, partnerships, or revenue guidance disclosed.","Presentation available at igcpharma.com and filed as Exhibit 99.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-22-001432","json":"https://secwatch.observer/filing/0001185185-22-001432.json","markdown":"https://secwatch.observer/filing/0001185185-22-001432.md","text":"https://secwatch.observer/filing/0001185185-22-001432.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326205/000118518522001432/0001185185-22-001432-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326205/000118518522001432/indiaglob20221219_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T01:32:04.344812+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}